COMP <GO>
ASST vs BRK-A // 10Y YIELD & FRED MACRO BETA
Strive Inc. (NASDAQ) VS. Berkshire Hathaway Inc. (Class A) (NYSE) • 15-METRIC TALLY: ASST 4
— BRK-A 7
▲ 10Y YIELD & FRED MACRO BETA LEADER: BRK-A
LAST: $20.80 (-6.28%) • MKT CAP: $2.83B
macro-sensitivity
0.89
LAST: $834,640.73 (+2.34%) • MKT CAP: $1.20T
macro-sensitivity
1.13
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASST VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ASST | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.80% | 11.47% | +7.33 | ASST | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.7x | 9.7x | +10.02 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 2.09% | +0.12 | ASST | /fcf-yield <GO> |
| Operating Margin | 13.90% | 27.80% | -13.90 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 22.30% | -11.40 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 3.93% | +176.07 | ASST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | ASST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.2 | 66.0 | -26.80 | BRK-A | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.89 | 1.13 | -0.24 | BRK-A | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 24.3x | +3.26 | BRK-A | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.83B | $1.20T | -$1.20T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ASST REV | BRK-A REV | ASST GROSS % | BRK-A GROSS % | ASST FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $313.1M | $247.24B | — | — | $0 | $25.04B |
| FY 2024 | $3.6M | $249.71B | — | — | -$21.6M | $11.62B |
| FY 2023 | $277.0K | $254.91B | — | — | -$3.8M | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASST // BETA 0.89
BRK-A // BETA 1.13